Imagine Eyes, a company based in Orsay, France, is making available its rtx1 Adaptive Optics Retinal Camera to ophthalmologists in Europe now that it’s CE Marked. The imaging system allows visualization of the retina at cellular scale, resolving …
Category: News
Corneal Surface Changes After Q-Value Guided LASIK and LASEK
How do visual acuity, corneal high-order aberrations, and changes in the anterior corneal surface compare between Q-value guided LASIK and LASEK? This new study looks at the two procedures. BMC Ophthalmology
Automatic 2% Medicare Cut Will Cost 767,000 Jobs, Study Says
Most of the lost jobs are outside healthcare. Organized medicine is urging Congress to spare physicians the consequences of ‘sequestration,’ scheduled for next year. Medscape Medical News
Readily available index provides practical landmarks for glaucoma patients
The mean deviation index, a widely understood metric for summarizing damage to an individuals’ visual field, could help physicians estimate practical landmarks in patients with glaucoma such as fitness to drive, report UK researchers.
12th EURETINA Congress
Read clinically focused news coverage of key developments from EURETINA 2012. Medscape Ophthalmology
Bioengineers design nanoparticles that can safely and predictably infiltrate deep into the brain
The brain is a notoriously difficult organ to treat, but Johns Hopkins researchers report they are one step closer to having a drug-delivery system flexible enough to overcome some key challenges posed by brain cancer and perhaps other maladies affecti…
GEN Reports On Ocular Therapeutics Targeting The Retina
Therapies for retinal diseases are expected to overtake those for glaucoma by 2014, reports Genetic Engineering & Biotechnology News (GEN). Because current retinal disease treatments only improve vision for six to eight weeks, there is a critical need…
Joslin Diabetes Center, Mass. Eye and Ear partner to form clinical and research alliance
Massachusetts Eye and Ear and the Joslin Diabetes Center announced today that they have reached agreement to form a clinical and research alliance, aimed toward providing coordinated high quality care to eye patients throughout greater Boston, especial…
Phase III data for Suvorexant, an investigational insomnia medicine, announced
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced new data for suvorexant, the investigational medicine Merck is developing for the treatment of insomnia. The new data are from one of the longest, continuously-dosed…
UC Irvine receives CIRM grant to advance stem cell-based treatments for AD, retinitis pigmentosa
Efforts to begin human clinical trials using stem cells to treat Alzheimer’s disease and retinitis pigmentosa received a $37.3 million boost from the California Institute for Regenerative Medicine during its most recent round of funding on Sept. 5.
Effects of Caffeinated Coffee Consumption on Glaucoma
Does caffeine consumption cause intraocular pressure to rise and, if so, what is the risk for patients with or at risk for glaucoma? Eye
20/20–Alcohol and Age-Related Macular Degeneration
Is there an association between moderate alcohol use and age-related macular degeneration? American Journal of Epidemiology
Corneal Flap Successfully Bound by Biological Adhesive
A biologic tissue adhesive protocol using fibrinogen, riboflavin, and ultraviolet light successfully bound corneal tissue of sharks and rabbits and may be useful for LASIK eye surgery. Medscape Medical News
Singapore Scientists Find Genes Associated With Glaucoma, A Major Cause Of Eye Blindness
Singapore scientists have identified three new genes associated with Primary Angle Closure Glaucoma (PACG), a leading cause of blindness in Chinese people. PACG affects 15 million people worldwide, 80% of whom live in Asia…
World’s First Bionic Eye Implant In Melbourne
Bionic Vision Australia researchers have successfully performed the first bionic eye implant of an early prototype at the Royal Victorian Eye and Ear Hospital in Melbourne. The bionic eye was implanted in a woman who has profound vision loss due to re…
Prompt Bevacizumab Helps Curb Macular Edema
Intraocular injections of bevacizumab (Avastin) are helpful in macular edema (ME) due to central retinal vein occlusion (CRVO), as long as they’re given promptly. Reuters Health Information
Omeros files OMS824 IND with FDA to initiate clinical trials for cognitive disorders
Omeros Corporation today announced that it has filed an Investigational New Drug Application (IND) with the U.S. Food and Drug Administration (FDA) to initiate clinical trials evaluating OMS824, the Company’s lead compound from its phosphodiesterase 10…
Lucentis® (Ranibizumab) For Treating Visual Impairment Due To Diabetic Macular Oedema, Study Shows New Evidence
RESTORE extension study demonstrates fully maintained initial vision gains with an average of 13.9 ranibizumab 0…
DuraSite 2 ophthalmic drug delivery system from InSite Vision
InSite Vision Incorporated today introduced DuraSite 2, its next-generation enhanced drug delivery system which provides a broad platform for developing superior ophthalmic therapeutics.
Scientists identify three new genes associated with Primary Angle Closure Glaucoma
Singapore scientists have identified three new genes associated with Primary Angle Closure Glaucoma (PACG), a leading cause of blindness in Chinese people. PACG affects 15 million people worldwide, 80% of whom live in Asia.